ABSTRACT. Thyroxine (T4) administration in mice during the 2nd wk of postnatal life elicits a precocious increase in submandibular gland-nerve growth factor (SMG-NGF) and epidermal growth factor (SMG-EGF) levels, but the mechanism(s) of T4 action has not been studied. The present report examines the role of the developing sympathetic nervous system (SNS) in the SMG-NGF and EGF responses to T4. For this purpose newborn mice were injected with T4 and/or 6-hydroxydopamine, a toxic congener of norephinephrine which causes selective destruction of sympathetic nerve terminals. The effectiveness of chemical sympathectomy was assessed by SMG-norepinephrine measurements using a sensitive radioenzymatic assay. The glandular norepinephrine contents were greatly reduced indicating that the dose and duration of 6-OHDA treatment were sufficient to cause a total sympathectomy in SMG tissue. In addition, the 6-OHDA treatment greatly reduced the wet weight and total protein content of the sympathetic superior cervical ganglia which innervate SMG tissue. SMG-NGF and EGF concentrations were measured by specific radioimmunoassays. 6-OHDA treatment alone did not affect the basal SMG-NGF and EGF concentrations. However, the maximal responses of SMG-NGF and EGF to T4 administration were greatly reduced by concurrent treatment with 6-OHDA. In summary, the data demonstrate a critical role for developing sympathetic nervous system in the T4-stimulated increase in SMG-NGF and EGF concentrations. (Pediatr Res 20: 232-236, 1986) Abbreviations T4, thyroxine SMG,-submandibular gland NGF, nerve growth factor EGF, epidermal growth factor SNS, sympathetic nervous system SCG, superior cervical ganglia NE, norepinephrine RIA, radioimmunoassay the autonomic nervous system (3). EGF is a polypeptide which exhibits a potent mitogenic effect on a wide variety of cell types (4). NGF and EGF are synthesized and stored in the CGT of the SMG (5, 6). SMG-NGF and EGF levels are low during the first three weeks of life in the mouse (7), a time when the SMG are grossly immature. Both SMG-NGF and EGF levels undergo exponential increases after weaning (i.e. 2 1 days) when the SMG exhibits rapid and maximal cytodifferentiation. In sexually mature animals the SMG exhibits sexual dimorphism with respect to structure (8) and growth factor content, including both NGF and EGF (9, 10). The factor(s) and the mechanism(s) that regulate these developmental changes are not fully understood.
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Several hormones are known to influence growth and maturation of mouse SMG (1 1, 12), including thyroxine, testosterone, and corticosterone, and these hormones have been recognized to augment the glandular contents of both NGF and EGF in adult animals (10, 13, 14) . However, the critical time period for the actions of these hormones on SMG-NGF and EGF and their participation in the normal ontogenesis of SMG-NGF and EGF are not clearly understood. Moreover, little information is available regarding the role of the autonomic nervous system in the growth and maturation of developing SMG (15, 16) . Recent studies in our laboratory have indicated that both SMG-NGF (17) and EGF (18) are T4 responsive during the second week of life. In view of the fact that T4 in newborn animals has profound effects on the developing nervous system (19, 20) , we examined the role of the SNS in mediating the T4 effect on developing SMG. The time of appearance of SMG-NGF and EGF response to T4 was studied in neonatal mice on day 16 following T4 and/ or 6-OHDA (a toxic congener of norepinephrine) administration from days 7-15. The data support a role for the developing SNS in mediating SMG-NGF and EGF responsiveness to T4.
MATERIALS AND METHODS
Animals. Time-dated, multiparous, pregnant Swiss-Webster mice were obtained from Simonsen Laboratories (Gilroy, CA). The mice were housed in the Harbor UCLA vivarium and given water and pelleted standard mouse chow ad libitum. Pups born within 16 h of each other were ~o o l e d and randomly distributed, eight pups per dam. The day of birth was counted as day zero. Four pups in each litter were marked by bobbing the tails. Each litter was housed with its mother in a plastic cage with wood Adult mouse SMG contains high concentrations of both NGF shavings for bedding. Cotton was added to all cages for warmth. and EGF (1, 2) . NGF is a protein that plays a key role in the Cages were changed daily and clean shavings replaced. growth and maintenance of sympathetic and sensory neurons of Four pups in each litter were treated as controls, while the remaining four (bobbed tails) served as experimental animals.
(0.4 pg/g body weightlday) in a 2 p1 volume of alkaline saline and/or 2 p1 of 6-OHDA (100 pg/g body weightlday) in ascorbic acid-saline solution. All injections were given from day 7 to 15. A total of 64 pups was used for each group. Animals were sacrificed on day 16 and each animal was weighed prior to sacrifice. Blood was collected from the inferior vena cava for determination of serum hormone concentrations. The SMG were removed, trimmed of connective tissue, weighed, and frozen immediately on dry ice for later measurements of NGF and EGF content. For glandular NE estimation individual glands were homogenized immediately in a Teflon-glass homogenizer at O-4" C in 1 ml volume of 0.1 N perchloric acid, containing 5 mM reduced glutathione. They were centrifuged at 15,000 x g for 30 min at 4" C. The supernatants were used for norepinephrine determination by a radioenzymatic assay (2 1).
For DNA determinations, pooled SMG tissues (four per tube) were homogenized in nine volumes of ice-cold distilled water and the homogenate was precipitated by adding perchloric acid to a final concentration of 10%. The precipitate was processed for DNA determination as previously described (1 7).
NGF and EGF RIA. SMG tissues were pooled to obtain sufficient material for measurement, usually four glands for control groups and two to three glands for animals treated with T4 and 6-OHDA. SMG tissues removed from animals receiving T4 injection alone were processed individually. As indicated, all glands were frozen on dry ice immediately after removal and stored at -70" C until further analysis. The tissues were homogenized in 10 volumes of 0.05 M phosphate buffered saline, pH 7.2; the homogenates were centrifuged at 145,000 x g for 1 h and the supernatants used for NGF and EGF determinations.
NGF RIA was performed using an NGF antiserum containing at least two populations of high affinity antibodies with a mean affinity constant of 5.8 x lo-'' liter/mol. The antiserum was used at a final dilution of 1:320,000. No cross reaction was observed with the a or -y subunits of 7 s NGF, renin, EGF or insulin when tested at 1 CLg/tube. The PNGF subunit and the 7 s NGF react similarly with the antiserum. The RIA can detect 16-20 pg/tube. Nonspecific binding was never more than 6% of total binding. NGF used for immunization, iodination, and standard was purified from adult male mouse SMG by the method of Mobley et al. (22) , as modified by Chapman et al. (23) . Iodination was performed with chloramine T (24) and labelled PNGF was purified on a CM-cellulose column using buffer systems similar to those employed for the purification of PNGF by Mobley et al. (22) . The specific radioactivity of Iz5I-NGF calculated using a self displacement assay ranged from 375-420 cpm/pg. Buffer, incubation and separation were previously described (25) .
The EGF-RIA was performed using an EGF antiserum containing two populations of high affinity antibodies with a mean affinity constant of 1 x lo-'' liter/mol. The antiserum was used at a final dilution of 1:250,000. No cross-reactivity was noted against renin, insulin, and myelin basic protein. Cross-reactivity with NGF was less than 0.01%. The antiserum binds both standard low molecular weight EGF (6045d) and high molecular weight EGF (74,000d). No cross-reaction was observed with purified EGF-binding protein (29,300d ). Non-specific binding was less than 4%. EGF used for iodination and standard was purified from SMG of adult male mice treated with testosterone propionate (26) . Iodination was performed using chloramine T and Iz5I-EGF was purified on a Sephadex G-25 column, developed and equilibrated with 0.05 M phosphate buffered saline. Specific radioactivity ranged from 600-800 cpm/pg. The buffer, incubation, and separation have been described previously (27) .
Serum hormone measurements. Serum T4 and T3 concentrations were measured using the methods of Chopra and coworkers (28, 29) .
STATISTICAL ANALYSIS
Data are expressed as mean + SEM. Since preliminary results indicated no differences in the various parameters measured between groups of animals treated with alkaline saline and ascorbic acid solutions, the data from both groups of animals were pooled and treated as representative of controls. For multiple comparison, the differences between means were determined by one way analysis of variance, followed by Student's Newman Keuls test. Significance was assumed at the 5% level ( p < 0.05).
RESULTS
Influence of T4 on somatic growth and serum hormones. The experimental design, body weights, SMG weights, and serumT4 and T3 concentrations are shown in Table 1 . Group A (control) animals were treated with vehicle solutions from days 7 to 15.
Groups B, C, and D received T4, 6-OHDA and T4 + 6-OHDA injections, respectively. All animals were sacrificed on day 16. Fig. 1 . Effect of neonatal T4 and/or 6-OHDA treatment on SMG-NE levels, wet weight, and protein content of sympathetic SCG. Newborn mice were treated with T4 and/or 6-OHDA from days 7-15 with doses as described in Table I . All pups were sacrificed on day 16. A, SMG-NE content as determined by a radioenzymatic assay (2 1). B, SCG wet weight determined on a Cahn electrical balance. C, total SCG protein content as determined by the method of Peterson (40) . The results obtained in three different experiments (3 X 6 animals/group) were not significantly different and were thus pooled. Values represent mean + SEM. measured by a radioenzymatic assay (21) . SMG-NE values were the T4-treated group compared to control animals ( p < 0.05).
reduced to less than 1 % of control levels in animals treated with Also, we examined the wet weight and total protein content of 6-OHDA and T4 + 6-OHDA, indicating a total chemical sym-SCG, the principle sympthetic ganglia that innervate SMG tissue. pathectomy (Fig. I A ) . The mean SMG-NE content increased in Both the ganglia wet weights (Fig. 1 B) and protein contents (Fig 1 C) were signficantly reduced in groups B, C, and D (B versus A, p < 0.05; C and D versus A, p < 0.01).
Effects of T4 and/or 6-OHDA administration on SMG-NGF and EGF SMG-NGF and EGF contents were measured by respective RIA methods; the results are shown in Figure 2 A 
DISCUSSION
The present study was restricted to one developmental period,
1.e. 7-15 days of age. Previous studies in this laboratory have indicated that both SMG-NGF and EGF acquire T4 responsiveness during the 2nd wk of life (17, 18) . Early actions of T4 on SMG include cytodifferentiation and organization (30) . However, thyroid hormones exert several other effects in neonatal rodents, including organization and maturation of the nervous and endocrine systems (19, 3 1, 32) . It is not clear whether the T4-induced increases in SMG-NGF and EGF levels are due to local SMG actions (activation of genes responsible for morphological and biochemical differentiation) or to accelerated development of the autonomic and endocrine systems. Studies with isoproterenol, a sympathomimetic amine, have shown that the SNS exerts a profound influence on the morphological and biochemical maturation of SMG in suckling rats (33) (34) (35) . The structural damage observed in SMG tissue as a consequence of anti-NGF treatment in preweaning animals provides further evidence for a critical trophic influence of the developing SNS on SMG tissue (36) .
To assess a role for the SNS of the T4-mediated SMG-NGF and EGF responses, we used four groups of animals that were treated with T4,6-OHDA, T4 + 6-OHDA or appropriate vehicle solutions. Pups treated with 6-OHDA (group C) and T4 + 6-
S M G -NGF

I 3
CONTROL OHDA (group D) showed marked reduction in growth, as indicated by their decreased body weight and nose to rump length measurements. T4 treatment alone had no effect on growth, but did advance the time of tooth eruption and eyelid opening by one full day compared to the control animals. Tooth eruption occurred in more than 75% of control animals (group A) on day 1 I, while this process was observed on day 10 in 80% of animals in T4-treated pups (group B). This finding is in close agreement with Lerman and Koldovsky (37) who reported accelerated rate of growth of teeth following T4 administration in rats during the second week of life. Eyelid opening occurred in 75% of control animals on day 14, whereas this process was completed in 82% of animals on day 13 in T4 treated pups (group B). 6-OHDA treatment given with T4 (group D) did not prevent the accelerated teeth eruption and eyelid opening. These results indicate that the T4 effects on epidermal maturation are not critically influenced by the developing SNS during the second week of life.
Animals treated with T4 + 6-OHDA (group D), however, exhibited dry and rough skin. These animals also had less hair than the other groups (A, B, and C), indicating some abnormality in cutaneous development.
T4 treatment (groups B and D) raised mean serum T4 and T3 levels indicating a hyperthyroid state in these animals. However, pups treated with T4 + 6-OHDA had higher mean levels of serum T3 than the groups of pups treated with T4 alone (group D versus B, p < 0.05). It is not clear whether the serum T3 increase in group D is due to alteration in the T4 to T3 conversion rate or is due to other alterations in T3 metabolism (tissue uptake or release). The lack of increase in mean serum T3 levels in 6-OHDA treated animals (group C) indicate that the drug treatment per se caused no alterations in the basal conversion of T4 to T3 or in T3 metabolism. Further work is necessary to determine the mechanism(s) by which 6-OHDA treatment influences the metabolism of exogenously administered T4 during the 2nd wk of life.
SMG relative weights were significantly greater in all three treated groups (B, C, and D) than in control animals (group A). The data on SMG-NE measurements confirmed that the dose S M G -EGF fl CONTROL Fig. 2 . Effect of neonatal T4 and/or 6-OHDA treatment on SMG-NGF ( A ) and EGF (B) levels. Littermate pups were treated with vehicle or T4 and 6-OHDA as described in Table 1 . They were sacrificed on day 16. NGF and EGF measurements were made in SMG tissues removed from animals sacrificed in the experiments described in Table 1 . and duration of 6-OHDA treatment were sufficient to cause a total destruction of sympathetic nerve terminals in SMG tissue. These results are in accordance with known effects of 6-OHDA treatment on sympathetic nerve terminals in this gland (38) . In addition, the observed reduction in SCG wet weight and protein content in groups C and D indicate that 6-OHDA treatment impaired SNS development. Interestingly, T4 treatment alone caused a moderate reduction in wet weight and protein content of SCG compared to control animals (group B versus A, p < 0.05). These results indicate that the developing SNS may be sensitive to T4 as is the brain (39) . Abnormalities ranging from defects in cell acquisition to inadequate development of dendritic spines have been reported in distinct brain regions of neonatal rodents treated with excess thyroid hormones early in life. In the present study the fact that T4 treatment alone (group B) did not decrease NE content in SMG tissue indicates that the action of T4 on the SCG size and protein content may be independent of its influence on sympathetic nerve terminals. Since SCG tissue represents a heterogenous population of cells, further work is necessary to delineate the nature of the cells and the individual constituents that may have been affected resulting in the reduction in ganglion size and protein content. The increases observed in mean SMG-NE content in T4 treated animals (NE, pg/gland 75150 + 2420 in T4-treated group versus 46066 + 4540 in vehicle treated group p < 0.05) may indicate the tendency of T4 treatment to cause accelerated maturation of sympathetic nerve terminals.
T4 treatment increased both SMG-NGF and EGF levels relative to control animals. These results are in agreement with our previous findings (1 7 , 18) . In addition, in the present studies we observed that 6-OHDA treatment alone did not affect the mean SMG-NGF and EGF levels. However, both growth factor levels were significantly lower in T4 + 6-OHDA treated pups compared to animals treated with T4 alone. These results indicated a requirement of sympathetic nerve terminals for maximal SMG-NGF and EGF responses to T4. The specific mechanism(s) by which sympathetic nerve terminals influence SMG-NGF and EGF responsiveness to T4 is not clear. Preliminary results show significant reduction in glandular DNA content in animals treated with 6-OHDA or T4 + 6-OHDA (total DNA pg/pair SMG in groups A, B, C, and D were 35 + 3; 5 1 f 3; 28 + 3 and 27 f 3, respectively). Thus, 6-OHDA treatment may have caused an impairment in cell acquisition. The identification of morphological (maturation of acini) and biochemical (appearance of several secretory proteins and increase in DNA synthesis) actions of isoproterenol on neonatal SMG early in life lends further support for a significant SNS role in the normal and differentiated functions of SMG tissue (33) (34) (35) . Whether other neuroeffector systems (parasympathetic and sensory nervous system) play a role in T4-mediated actions remains an interesting aspect for further study.
